PMH17 HEALTH CARE COSTS ASSOCIATED WITH TREATMENT OF BIPOLAR DISORDER USING A MOOD STABILIZER PLUS ADJUNCTIVE ARIPIPRAZOLE, QUETIAPINE, RISPERIDONE, OLANZAPINE OR ZIPRASIDONE
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73938-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)73938-3/fulltext
Section Title :
Section Order :
421
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73938-3&doi=10.1016/S1098-3015(10)73938-3